| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |